- Q1 2024 Vericel Corp Earnings Call TranscriptMay 08, 2024$47.69 (-3.70%)Earnings
- Q4 2023 Vericel Corp Earnings Call TranscriptFeb 29, 2024$45.68 (-4.44%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Vericel Corp Earnings Call TranscriptNov 08, 2023$35.27 (-3.40%)Earnings
- Vericel Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Vericel Corp Earnings Call TranscriptAug 02, 2023$34.63 (-1.40%)Earnings
- Q1 2023 Vericel Corp Earnings Call TranscriptMay 10, 2023$34.19 (+4.11%)Earnings
- Q4 2022 Vericel Corp Earnings Call TranscriptFeb 23, 2023$30.6 (+7.29%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Vericel Corp Earnings Call TranscriptNov 09, 2022$17.65 (-23.43%)Earnings
- Q2 2022 Vericel Corp Earnings Call TranscriptAug 03, 2022$31.73 (-0.25%)Earnings
- Q1 2022 Vericel Corp Earnings Call TranscriptMay 04, 2022$31.05 (-0.99%)Earnings
- Q4 2021 Vericel Corp Earnings Call TranscriptFeb 24, 2022$38.88 (+20.82%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Vericel Corp Earnings Call TranscriptNov 09, 2021$42.15 (-2.20%)Earnings
- Vericel Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Vericel Corp Earnings Call TranscriptAug 04, 2021$49.18 (-4.91%)Earnings
- Vericel Corp at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 13, 2021
- Vericel Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Q1 2021 Vericel Corp Earnings Call TranscriptMay 05, 2021$56.59 (-4.33%)Earnings
- Vericel Corp Annual Shareholders Meeting TranscriptApr 28, 2021
- Q4 2020 Vericel Corp Earnings Call TranscriptFeb 24, 2021$49.45 (+4.39%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Vericel Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Vericel Corp Earnings Call TranscriptNov 05, 2020$21.73 (+2.50%)Earnings
- Vericel Corp Corporate Analyst Meeting TranscriptOct 16, 2020
- Vericel Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Vericel Corp Earnings Call TranscriptAug 05, 2020$15.92 (-5.35%)Earnings
- Vericel Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q1 2020 Vericel Corp Earnings Call TranscriptMay 05, 2020$14.42 (+2.85%)Earnings
- Q4 2019 Vericel Corp Earnings Call TranscriptFeb 25, 2020$16.69 (-11.65%)Earnings
- Vericel Corp at Needham Growth Conference TranscriptJan 15, 2020
- Q3 2019 Vericel Corp Earnings Call TranscriptNov 05, 2019$18.34 (+12.86%)Earnings
- Vericel Corp at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Vericel Corp Earnings Call TranscriptAug 06, 2019$18.6 (+5.14%)Earnings
- Vericel Corp at UBS Global Healthcare Conference TranscriptMay 22, 2019
- Q1 2019 Vericel Corp Earnings Call TranscriptMay 07, 2019$17.3 (-5.98%)Earnings
Vericel Corp at JPMorgan Healthcare Conference Transcript
Good morning. Welcome, everyone, to the third day of the 41st JPMorgan Conference. Here we go. We're thrilled to have you here, and we're thrilled to have the Vericel team as well. We've got Nick Colangelo, President and CEO, here to present. I'll go ahead and pass it over to Nick.
Okay. Well, thanks, [James]. It's great to be here today. And before I begin, I just want to remind everyone that this presentation contains forward-looking statements, and you should refer to our documents on file with the SEC for further information.
So for those of you who are not as familiar with our company, Vericel is a leader in advanced therapies for the sports medicine and the severe burn care markets. We have a portfolio of highly innovative advanced cell therapies and specialty biologics that are really focused on changing the standard of care for patients with cartilage injuries and severe burns.
We currently market 2 products in the United States. They're both
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)